{"version":"1.0","provider_name":"The Medical Xchange","provider_url":"https:\/\/themedicalxchange.com\/en\/","title":"Serum Uric Acid Emerging as Sensitive Risk Factor for Cardiovascular Disease, Renal Disease, and Death - The Medical Xchange","type":"rich","width":600,"height":338,"html":"<blockquote class=\"wp-embedded-content\" data-secret=\"yK9WSnpsAu\"><a href=\"https:\/\/themedicalxchange.com\/en\/2011\/11\/08\/american-society-of-nephrology-kidney-week-2011\/\">Serum Uric Acid Emerging as Sensitive Risk Factor for Cardiovascular Disease, Renal Disease, and Death<\/a><\/blockquote><iframe sandbox=\"allow-scripts\" security=\"restricted\" src=\"https:\/\/themedicalxchange.com\/en\/2011\/11\/08\/american-society-of-nephrology-kidney-week-2011\/embed\/#?secret=yK9WSnpsAu\" width=\"600\" height=\"338\" title=\"&#8220;Serum Uric Acid Emerging as Sensitive Risk Factor for Cardiovascular Disease, Renal Disease, and Death&#8221; &#8212; The Medical Xchange\" data-secret=\"yK9WSnpsAu\" frameborder=\"0\" marginwidth=\"0\" marginheight=\"0\" scrolling=\"no\" class=\"wp-embedded-content\"><\/iframe><script type=\"text\/javascript\">\n\/* <![CDATA[ *\/\n\/*! This file is auto-generated *\/\n!function(d,l){\"use strict\";l.querySelector&&d.addEventListener&&\"undefined\"!=typeof URL&&(d.wp=d.wp||{},d.wp.receiveEmbedMessage||(d.wp.receiveEmbedMessage=function(e){var t=e.data;if((t||t.secret||t.message||t.value)&&!\/[^a-zA-Z0-9]\/.test(t.secret)){for(var s,r,n,a=l.querySelectorAll('iframe[data-secret=\"'+t.secret+'\"]'),o=l.querySelectorAll('blockquote[data-secret=\"'+t.secret+'\"]'),c=new RegExp(\"^https?:$\",\"i\"),i=0;i<o.length;i++)o[i].style.display=\"none\";for(i=0;i<a.length;i++)s=a[i],e.source===s.contentWindow&&(s.removeAttribute(\"style\"),\"height\"===t.message?(1e3<(r=parseInt(t.value,10))?r=1e3:~~r<200&&(r=200),s.height=r):\"link\"===t.message&&(r=new URL(s.getAttribute(\"src\")),n=new URL(t.value),c.test(n.protocol))&&n.host===r.host&&l.activeElement===s&&(d.top.location.href=t.value))}},d.addEventListener(\"message\",d.wp.receiveEmbedMessage,!1),l.addEventListener(\"DOMContentLoaded\",function(){for(var e,t,s=l.querySelectorAll(\"iframe.wp-embedded-content\"),r=0;r<s.length;r++)(t=(e=s[r]).getAttribute(\"data-secret\"))||(t=Math.random().toString(36).substring(2,12),e.src+=\"#?secret=\"+t,e.setAttribute(\"data-secret\",t)),e.contentWindow.postMessage({message:\"ready\",secret:t},\"*\")},!1)))}(window,document);\n\/\/# sourceURL=https:\/\/themedicalxchange.com\/wp-includes\/js\/wp-embed.min.js\n\/* ]]> *\/\n<\/script>\n","thumbnail_url":"https:\/\/themedicalxchange.com\/wp-content\/uploads\/2011\/11\/ASN_2322_Figure_1.PNG","thumbnail_width":960,"thumbnail_height":720,"description":"Philadelphia \u2013 Elevated serum uric acid (SUA) is an important treatable biomarker for renal and cardiovascular (CV) disease, according to data presented at Kidney Week 2011. Elevated SUA was associated with progressive renal disease, increasing rates of CV events, and mortality. These associations persist after controlling for co-morbidities. In one study, the mortality risk climbed even higher in patients with both elevated SUA and gout. Data presented here support screening for elevated SUA and implementing effective intervention when levels are elevated."}